Gastroparesis Treatment Market Analysis
The global Gastroparesis Drugs Market is predicted to touch USD 5,323.62 million at a 3.8% CAGR o
ver the forecast period (2016-2023), in accordance with the latest Market Research Future (MRFR) report. Gastroparesis means stomach paralysis. This is basically a digestive disorder where stomach mobility is absent or abnormal. During this condition, the stomach is not capable of contracting normally, thus cannot propel food nor crush food properly in the small intestine. As a result, there will be no normal digestion.
Free Sample Copy of With Considering Coivd19 Impact on this Market @https://www.marketresearchfuture.com/sample_request/3213
Gastroparesis
may interfere with normal digestion resulting in vomiting and nausea,
and also cause issues with nutrition and blood sugar levels. At times
this is a complication of diabetes while there are some that develop it
after surgery. Pain in the stomach, lack of appetite, abdominal
bloating, gastroesophageal reflux, the feeling of fullness, and nausea
are some of the usual symptoms of gastroparesis.
There
are several causes of gastroparesis, of which diabetes is the most
common. Other causes include upper intestinal tract surgery, some
chemotherapy agents, radiation treatment applied over the abdomen or
chest, certain cancers, eating disorders, psychological conditions,
idiopathic causes, neuromuscular diseases, autoimmune conditions,
connective tissue disorder such as scleroderma, endocrine disorders such
as hypothyroidism, and infections.
Various
factors are propelling the gastroparesis treatment market growth. These
factors, in accordance with the MRFR report, include the focus of key
market players in R&D for launching specific drugs to treat
gastroparesis, the introduction of new drugs, increasing number of
surgeries resulting in post-operative gastroparesis, and increasing
prevalence of diabetes mellitus.
On
the contrary, lack of awareness about gastroparesis as well as its
available treatments, the strict regulatory environment for new drug
approval, side effects of gastroparesis drugs, and use of
non-prescription drugs are factors that may restrict the gastroparesis
treatment market growth over the forecast period.
Gastroparesis Treatment Market Segmentation
The MRFR report provides a complete segmental analysis of the gastroparesis treatment market report on the basis of type, drug class, and treatment.
Based
on gastroparesis type, the gastroparesis treatment market is segmented
into post-surgical, diabetic, idiopathic, and others. Of these, the
idiopathic gastroparesis will have the largest share in the market over
the forecast period.
Based
on drug class, the gastroparesis treatment market is segmented into
antidepressants, antiemetics, prokinetic drugs, and others. Of these,
the prokinetic drugs segment will dominate the market over the forecast
period. This is owing to its ease of availability, effectiveness,
increasing applicability and high usage to treat gastroparesis.
Based
on treatment, the gastroparesis treatment market is segmented into
parenteral nutrition, gastric electric stimulation, and jejunostomy.
Gastroparesis Treatment Market Regional Analysis
By
region, the gastroparesis treatment market report covers the latest
trends and growth opportunities across Europe, the Americas, the Asia
Pacific (APAC), and the Middle East and Africa (MEA). Of these, the
Americas will remain at the forefront in the market over the forecast
period. This is owing to the region’s good reimbursement scenario and
constant technological advancement. Moreover, an increase in the number
of diabetic patients in the region is also boosting the market growth.
Diabetic gastroparesis is a major type of gastroparesis that is
affecting the population in this region.
The
gastroparesis treatment market in Europe is predicted to have the
second-largest share in the market over the forecast period, but the
sluggish economy in this region is predicted to restrict the market
growth.
The
gastroparesis treatment market in the APAC region is predicted to grow
at the highest CAGR over the forecast period. This is owing to unmet
needs, larger patient population, rise in product approvals, and
government focus to improve health care facilities.
The gastroparesis treatment market in the MEA will have slow growth in the market over the forecast period.
Key Players
Leading
players profiled in the gastroparesis treatment market report include
Rhythm Pharmaceuticals, Inc., Evoke Pharma, Alfa Wassermann SPA,
Cardinal Health, Inc., Janssen Global Services, LLC, C. R. Bard, Inc.,
Boston Scientific Corporation, Salix Pharmaceuticals, Inc., Abbott
Laboratories, Kimberly-Clark Corporation, and Medtronic. Key players
adopted strategies such as expansions, collaborations, research and
development, mergers and acquisitions, and more to strengthen their
position in the market.
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/gastroparesis-treatment-market-3213
Related reports link:-
Amd Marketing
E Health Services
Monistat Cream in India
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
0 Comments